邯郸怀孕的症状有哪些(邯郸阴道 肉芽) (今日更新中)

The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.The FDA initially announced a valsartan recall in July after lab tests discovered that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had previously been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were impacted.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and can be unintentionally introduced through certain chemical reactions. It's a byproduct from the manufacturing of some pesticides and fish processing. 956

The University Hospitals Fertility Clinic in Cleveland is facing dozens of legal actions after the failure in early March of a cryopreservation tank containing approximately 4,000 eggs and embryos belonging to at least 950 families."We currently represent well over 100 clients whose cases we will pursue as individual claims. That number is growing by the day," Cleveland attorney Tom Merriman said Monday.Also Monday, attorney Gloria Allred threw her hat into the ring, announcing litigation on behalf of three Pittsburgh women who are all cancer survivors. 567

The US Department of Education has opened an investigation into the Ohio State University's handling of former students' allegations of sexual misconduct by a school doctor, according to the university.The federal investigation will be conducted by the department's Office for Civil Rights (OCR), which oversees Title IX complaints, the school said in a statement Thursday.The inquiry, led by the OCR's regional office in Cleveland, Ohio, "will examine whether the university is responding promptly and equitably to complaints and reports by former students," the statement said, "including allegations that employees knew or should have known about the sexual misconduct and allowed the abuse to continue."The scandal surrounding the alleged actions of the late Dr. Richard Strauss has grown since the university first announced in April its own investigation, headed by the law firm Perkins Coie, to look into claims made by male former athletes on 14 sports teams.Since then, more than 100 former Ohio State University students have reported firsthand accounts of sexual misconduct by Strauss, the school said last month.Some of them, mostly former student athletes, have come forward to publicly claim that Strauss sexually abused them under the guise of a medical examination.According to the school, the alleged abuse took place between 1979 and 1997."We welcome the involvement and careful oversight of OCR and look forward to providing any information we can," said Gates Garrity-Rokous, the school's vice president and chief compliance officer, in a statement about the US Department of Education's investigation."We responded promptly and appropriately to the allegations received in April about Dr. Strauss," Garrity-Rokous continued. "We are confident in the independence and thoroughness of the investigation we launched then as well as our ongoing commitment to transparency."The-CNN-Wire 1910

The terror attack on New York City's West-Side bike path has President Trump calling for congress to eliminate the "Diversity Visa" program.Congress created it in 1990. It was signed into law by President George W. Bush.Among the San Diegans who are here because of the visa program is Anna Riazanova.In 1993, Riazanova, a native of Russia, entered the U.S. on a student visa and began studying to become a paralegal."I fell in love with the country, the people," said Riazanova.A year later, she applied for the Diversity Visa Lottery program, aimed at diversifying immigration by randomly selecting 50,000 green card applicants every year from countries with historically low U.S. immigration rates. 709

The Trump Administration pushed through a million contract to study whether the active ingredient in Pepcid is an effective treatment for Covid-19. That contract is now under scrutiny after a government whistleblower accused a senior administration official of rushing the deal through without the scientific oversight necessary for such a large federal award. The Food and Drug Administration gave the clinical trial speedy approval even as a top agency official worried that daily injections of high doses of famotidine for already sick patients pushed the levels of what was considered safe “to the limits,” internal government emails show. And the doctors who initially pushed the Pepcid idea are locked in a battle for credit and sniping over allegations of scientific misconduct.The origins of the interest in famotidine are under dispute, but there were reports out of China that patients who took the drug survived the virus, while patients who took other heartburn medications were not surviving. Initial observational studies in the U.S. were promising, however scientists urged more research was needed. Meantime, the trial itself that was part of the million contract is on pause due to a shortage of hospitalized COVID-19 patients in New York, delaying it indefinitely. A vaccine or effective treatment could be available before the study is complete. 1380

来源：资阳报